Short-term Endothelin A Receptor Blockade in Patients With On-pump CABG
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.
Also called NCT01658410
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT01658410
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Austria
- Registry status
- Unknown status
Technical summary
Registry record NCT01658410. Randomized; triple masking; primary purpose treatment. Start 2012-07 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Short-term Endothelin A Receptor Blockade in Patients With On-pump CABG
- Condition
- Coronary Artery Disease
- Condition
- Aorto-coronary Bypass Grafting
- Intervention (Drug)
- BQ-123
- Intervention (Drug)
- NaCl
- Lead sponsor
- Medical University of Vienna
Record details
- Record id
cardio:ct-nct01658410- Content hash
cf77dddc61272a4fa19d2de5758e5ee834762e4f474bde509389964968b042b2